Related Experiment Video
Updated: Aug 23, 2026

A Fast and Reliable Pipeline for Bacterial Transcriptome Analysis Case study: Serine-dependent Gene Regulation in Streptococcus pneumoniae
Published on: April 25, 2015
[Analysis of the resistance gene in Streptococcus pneumoniae]
Hitoshi Miyamoto1, Mitsuharu Murase
1Department of Clinical Laboratory, Ehime University Hospital.
Abstract:
Resistance genes were determinded for 81 strains of Streptococcus pneumoniae isolated from Ehime University hospital, during 2002 and 2003 by various clinical material. In penicillin-binding proteins of mutation, there were 74 strains; pbp2x mutation 23 strains (28.4%), pbp2b mutation one strain (1.2%), pbp1a + pbp2x mutations 5 strains (6.2%), pbp2x + pbp2b mutations 18 strains (22.2%) and all mutations 27 strains (33.3%). As for the result of macrolide resistance genes, there were 67 strains; mefA gene 20 strains (24.7%), ermB gene 46 strains (56.8%) and both gene one strain (1.2%). In the analysis of gyrA gene and parC gene, 3 strains (3.7%) had both gene mutations, and 26 strains (32.1%) had only parC gene mutation. There was more of an increase than before in isolates, two or more mutation strains with PBPs gene, ermB gene holding strains and the levofloxacin resistance strain. These results suggest that the gyrA gene or parC gene mutation strains hold PBPs gene mutation and macrolide resistance genes in a high rate, and there will be more drug resistance in the future.
Insights
Streptococcus pneumoniae strains show increasing resistance to antibiotics like penicillin and macrolides due to gene mutations. This rise in antimicrobial resistance, particularly in fluoroquinolone-resistant strains, signals future treatment challenges.
Area of Science:
- Microbiology
- Genetics
- Infectious Diseases
Context:
- Investigated antimicrobial resistance in *Streptococcus pneumoniae*.
- Analyzed 81 clinical isolates from Ehime University Hospital (2002-2003).
- Focused on resistance mechanisms in penicillin-binding proteins (PBPs), macrolide resistance genes, and fluoroquinolone resistance genes.
Purpose:
- Determine the prevalence of specific resistance genes in *Streptococcus pneumoniae*.
- Identify mutations in penicillin-binding protein (PBP) genes (pbp2x, pbp2b, pbp1a).
- Characterize macrolide resistance genes (mefA, ermB) and fluoroquinolone resistance genes (gyrA, parC).
Summary:
- High rates of PBP mutations were observed, with combined mutations in pbp2x and pbp2b being common.
- The *ermB* gene was the predominant macrolide resistance gene, found in 56.8% of isolates.
- Fluoroquinolone resistance was associated with *gyrA* and *parC* gene mutations, with *parC* mutations being more frequent.
Impact:
- Observed a concerning increase in multi-drug resistant strains, including those with PBP and *ermB* gene mutations.
- Found a high co-occurrence of *gyrA*/*parC* mutations with PBP and macrolide resistance genes.
- Suggests a growing trend of antimicrobial resistance in *Streptococcus pneumoniae*, necessitating further surveillance and treatment strategy development.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Antibiotic Selection
Gene Regulation in Microbial Communities: Quorum Sensing
Clinical Significance of Antibiotic Resistance
Atypical Pneumonia

